TA

Tariq Arshad

Executive Vice President, Chief Medical Officer

Bexion Pharmaceuticals

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Bexion Pharmaceuticals
Industry
biotechnology
Employees
26.0
Seniority
C suite
Annual Revenue
3000000.0
Total Funding
18000000.0
Latest Funding
Other

Technologies

Cloudflare DNS Outlook CloudFlare Hosting WordPress.org Google Analytics Bootstrap Framework Google Font API Mobile Friendly Google Tag Manager reCAPTCHA Remote AI

Keywords

oncology neuropathy innovation quality manufacturing research development great place to work leadership service integrity commitment passion transformative therapy biopharmaceutical biotechnology novel s1p modulator cns bxq-350 biopharmaceuticals clinical trials chemotherapy-induced peripheral neuropathy cipn solid tumors novel drug development pharmacology neuroprotective properties sphingosine-1-phosphate ceramide modulation apoptosis chemotherapy patient advocacy pediatric cancers dipg glioma tumor microenvironment saposin c bioactive sphingolipids emerging therapies fda approval multinational clinical studies drug formulation biologic therapy metastatic colorectal cancer mcrc preclinical studies fast track designation personalized medicine investigational new drug orphan drug status safety & efficacy phase 1 trials bioinnovation drug delivery regulatory compliance clinical pharmacokinetics tumor microenvironment modulation biotech leadership research & development patient outcomes business development strategic partnerships cancer therapies hospital & health care mechanical or industrial engineering health care health wellness & fitness b2b

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans